MeSH tree: D27
Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage. University of Mississippi researchers are examining why and where that leaves patients.
Jul 20, 2026
0
4
Significant advances have been made in the development of patient-derived tumor "organoids" for preclinical research in two new studies led by Weill Cornell Medicine investigators. Organoids are three-dimensional clumps of ...
Jul 20, 2026
0
3
More than half of U.S. adults ages 30 to 79—about 87.5 million people—are now recommended for statins to prevent cardiovascular disease under newly updated clinical guidelines, according to a study by University of Pittsburgh ...
Jul 20, 2026
0
10
From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval are often ...
Jul 20, 2026
0
6
Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in preclinical studies. It's a major development for this type of immunotherapy, which has been used ...
Jul 19, 2026
0
11
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss. Some research ...
Jul 17, 2026
0
6
For veterans with type 2 diabetes (T2D) receiving basal insulin therapy, the addition of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) does not increase the rate of insulin discontinuation compared with other glucose-lowering ...
Jul 16, 2026
0
5
The popularity of GLP-1 drugs has created a new generation of body contouring patients and a new set of challenges for plastic surgeons.
Jul 16, 2026
0
6
Heat-related deaths in the U.S. have surged more than 50% since 2000 as the climate warms and temperatures rise to record-breaking levels. This July alone, more than half of Americans were exposed to extreme temperatures ...
Jul 16, 2026
0
5
Cambridge researchers have shown how commonly used sweeteners slow the growth of certain gut bacteria. One sweetener in particular—isosteviol—when combined with the antidepressant duloxetine, significantly impaired two important ...
Jul 16, 2026
0
26
